New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
10:26 EDTWOPEY, NGG, AWAY, EDPFY, DSW, CELG, PAGP, MDAS, HSY, DG, CS, BMO, NJR, MANU, FIATY, DLR, CRZBDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Bank of Montreal (BMO) downgraded to Sector Perform from Outperform at RBC Capital... Celgene (CELG) downgraded to Neutral from Overweight at JPMorgan... Commerzbank (CRZBD) downgraded to Neutral from Outperform at Exane BNP Paribas... Credit Suisse (CS) downgraded to Neutral from Buy at BofA/Merrill... DSW (DSW) downgraded to Neutral from Positive at Susquehanna... Digital Realty (DLR) downgraded to Hold from Buy at Cantor... Dollar General (DG) downgraded at Sterne Agee... Energias de Portugal (EDPFY) downgraded to Sell from Neutral at Citigroup... Fiat (FIATY) downgraded to Underperform from Market Perform at Bernstein... Hershey (HSY) downgraded to Hold from Buy at Argus... HomeAway (AWAY) downgraded to Neutral from Overweight at JPMorgan... Manchester United (MANU) downgraded to Neutral from Overweight at JPMorgan... MedAssets (MDAS) downgraded to Neutral from Buy at Citigroup... National Grid (NGG) downgraded to Neutral from Outperform at Credit Suisse... New Jersey Resources (NJR) downgraded to Hold from Buy at Brean Capital... Plains GP Holdings (PAGP) downgraded to Equal Weight from Overweight at Stephens... Woodside Petroleum (WOPEY) downgraded to Market Perform from Outperform at Bernstei.
News For BMO;CELG;CRZBD;CS;DSW;DLR;DG;EDPFY;FIATY;HSY;AWAY;MANU;MDAS;NGG;NJR;PAGP;WOPEY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
January 28, 2016
09:28 EDTHSYHershey CEO says open to growing through M&A
Hershey CEO John P. Bilbrey, speaking on the company's Q4 earnings call, said the company's balance sheet and cash flows remain strong, adding "we'll continue to be disciplined and open to sources of growth via M&A."
08:09 EDTCELGAlliqua announces partnership with Human Longevity
Subscribe for More Information
07:36 EDTCELGCelgene sees Q1 adjusted EPS $1.27-$1.30, consensus $1.30
07:36 EDTCELGCelgene sees FY16 adjusted EPS $5.50-$5.70, consensus $5.69
Subscribe for More Information
07:31 EDTCELGCelgene reports Q4 adjusted EPS $1.18, consensus $1.22
Reports Q4 revenue $2.56B, consensus $2.54B.
07:07 EDTBMOBank of Montreal receives regulatory approvals for NCIB
Subscribe for More Information
07:05 EDTHSYHershey sees long term constant currency net sales growth 3%-5%
Subscribe for More Information
07:04 EDTHSYHershey sees FY16 EPS $4.18-$4.23, consensus $4.38
Subscribe for More Information
07:02 EDTHSYHershey reports Q4 adjusted EPS $1.08, consensus $1.05
Subscribe for More Information
07:00 EDTHSYHershey announces $500M share repurchase authorization
Hershey announced that its board has approved an additional $500M stock repurchase authorization to repurchase shares of its Common Stock. Purchases under the new authorization will commence after the current program is completed. Hershey is authorized to purchase its outstanding shares in open market and privately negotiated transactions. The program has no expiration date and acquired shares of the Common Stock will be held as treasury shares. Similar to prior programs, approved share repurchase authorizations are in addition to Hershey's practice of buying back shares sufficient to offset those issued under incentive compensation plans.
January 27, 2016
14:34 EDTCELGNotable companies reporting before tomorrow's open
Subscribe for More Information
14:29 EDTCELGCelgene technical remarks ahead of earnings news
Subscribe for More Information
12:19 EDTCELGPiper Jaffray biopharma analyst holds an analyst/industry conference call
Subscribe for More Information
10:31 EDTMDASPamplona Capital completes acquisition of MedAssets
Pamplona Capital Management has completed the acquisition of MedAssets. As a result of the transaction, MedAssets stock will stop trading at the close of business today. Pamplona purchased MedAssets for $31.35 per share, which represents a total enterprise value of approximately $2.7B. The transaction was overwhelmingly approved by stockholders on January 14, with 99.8% of total votes cast in favor. Separately, Pamplona has entered into an agreement with Vizient to divest MedAssets' Spend and Clinical Resource Management segment to Vizient. That transaction is expected to be completed in mid-February 2016.
January 26, 2016
18:18 EDTMDASS&P announces changes to S&P 500, S&P SmallCap 600 indices
Subscribe for More Information
17:19 EDTMDASZELTIQ to replace MedAssets in S&P 600 as of 1/29 close
Subscribe for More Information
January 25, 2016
11:05 EDTCELGOncoMed price target lowered to $29 from $43 at Piper Jaffray
Subscribe for More Information
10:57 EDTCELGCelgene management to meet with Evercore ISI
Meeting to be held in Canada on February 1 hosted by Evercore ISI.
09:33 EDTHSYHershey downgraded to Mixed from Positive at OTR Global
Subscribe for More Information
05:36 EDTCELGStocks with implied volatility below IV index mean; CELG INTC
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use